bpc-157 in functional medicine Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review BPC-157 Delayed | Fullscript

Optimizing results with lifestyle factors Cagrilintide provides powerful metabolic support, but lifestyle factors determine how much of that potential translates into actual results

Adherence is the key problem!If 70% of the patient discontinue the treatment after 6-12 month and regain the weight very quickly, handling the adherence weakness is much more helpful to the patient's health than another 3% weight loss.Alma's smart capsule we can probably load GLP1 or Amylin on a once / twice weekly oral dose

VMD: visual molecular dynamics

Persistent metabolic adaptation 6 years after The Biggest Loser competition

"Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial"

Sikiric et al., 1993